BDNF and Alzheimer disease: Thus, the use of circulating BDNF through peripheral blood fulfills the effectiveness of this biomarker; however, further validation in properly wide longitudinal studies comparing to current consolidated biomarkers of AD should be conducted to include BDNF as a valid molecular biomarker.